Assay, kinetics and properties of plasma adenosine diphosphatase. The relationship to acid and alkaline phosphatase and variations in disease.
A rapid radioassay was used to characterise the adenosine diphosphatase (ADPase) activities in human plasma. There was a major peak at pH 9.3, 80% of whose activity was attributable to non-specific alkaline phosphatase, with the remaining 20% probably due to a specific ADPase. There was also a small peak of ADPase activity at pH 4.0. Inhibitor and chromatographic studies showed that whilst much of this activity was attributable to non-specific acid phosphatase, there was a discrete acid ADPase. Assays of plasma ADPase activities in vascular disorders, including myocardial infarction, peripheral vascular disease and diabetes mellitus, reveal no alterations from control values. Activities of alkaline ADPase were elevated in both chronic and acute liver failure. Acid ADPase was also increased in chronic liver disease and it is suggested that alterations in ADPase activities in liver disorders may contribute to the haemostatic problems observed in these patients.
D000135:Acid Phosphatase / Q000097:blood*; D000208:Acute Disease; D000469:Alkaline Phosphatase / Q000097:blood*; D001081:Apyrase / Q000037:antagonists & inhibitors / Q000097:blood*; D002850:Chromatography, Gel; D002908:Chronic Disease; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008107:Liver Diseases / Q000097:blood*; D009203:Myocardial Infarction / Q000097:blood; D010744:Phosphoric Monoester Hydrolases / Q000097:blood*; D014652:Vascular Diseases / Q000097:blood
D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D010744:Phosphoric Monoester Hydrolases; D001081:Apyrase